Article Text

other Versions

PDF
Distribution of Angiographic Measures of Restenosis Post Drug-Eluting Stent Implantation
  1. Robert A Byrne (byrne{at}dhm.mhn.de)
  1. Deutsches Herzzentrum Munich, Germany
    1. Sonja Eberle (sonja.s.eberle{at}gsk.com)
    1. GlaxoSmithKline GmbH & Co KG, Munich, Germany
      1. Adnan Kastrati (kastrati{at}dhm.mhn.de)
      1. Deutsches Herzzentrum Munich, Germany
        1. Alban Dibra
        1. Deutsches Herzzentrum Munich, Germany
          1. Gjin Ndrepepa (ndrepepa{at}dhm.mhn.de)
          1. Deutsches Herzzentrum Munich, Germany
            1. Raisuke Iijima (raisuke{at}live.jp)
            1. Deutsches Herzzentrum Munich, Germany
              1. Julinda Mehilli (mehilli{at}dhm.mhn.de)
              1. Deutsches Herzzentrum Munich, Germany
                1. A Schömig (aschoemig{at}dhm.mhn.de)
                1. Medizinische Klinik rechts der Isar, Technische Universität, Munich, Germany

                  Abstract

                  Objective: A bimodal distribution of measures of restenosis has been demonstrated at 6-8 months following bare metal stent implantation. Drug-eluting stent (DES) therapy has attenuated the impact of certain factors (e.g. diabetes) on restenosis but its effect on the distribution of indices of restenosis is not known. We performed detailed analysis of the metrics of restenosis indices following DES implantation.

                  Design, settings, patients: Prospective observational study of patients undergoing DES implantation (Cypher, sirolimus-eluting stent; or Taxus, paclitaxel-eluting stent) at two German centres, with repeat angiography scheduled at 6-8 months after coronary stenting.

                  Main outcome measures: In-stent late luminal loss (LLL) and in-segment percentage diameter stenosis (%DS) as determined by quantitative coronary angiography at re-catheterization.

                  Results: Paired cineangiograms were available for 2057 patients. Overall mean LLL was 0.31±0.50 mm; mean %DS was 30.3±15.7. Distribution of both LLL and %DS differed significantly from normal (Kolmogorov-Smirnov test; p<0.001 for each). For both parameters a mixed distribution better described the data (likelihood ratio test with 3df; p<0.001 for each). This consisted of two normally-distributed sub-populations with means of 0.10±0.25 mm and 0.69±0.60 mm for LLL, and means of 22.2±8.6 and 40.1±16.6 for %DS. No effect of stent type on distribution patterns was evident when data was analyzed according to type of stent implanted.

                  Conclusions: Late loss and percentage diameter stenosis at follow-up angiography post DES implantation have a complex mixed distribution that may be accurately represented by a bimodal distribution model. The introduction of DES therapy has not resulted in elimination of a variable propensity to restenosis among subpopulations of stented lesions.

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                  Linked Articles